Literature DB >> 22261453

Image analysis of HER2 immunohistochemical staining. Reproducibility and concordance with fluorescence in situ hybridization of a laboratory-validated scoring technique.

Douglas M Minot1, Jesse Voss, Susan Rademacher, Toe Lwin, Jessica Orsulak, Bolette Caron, Rhett Ketterling, Aziza Nassar, Beiyun Chen, Amy Clayton.   

Abstract

Image analysis of the HER2 immunohistochemical (IHC) stain can help determine which breast cancer patients may benefit from HER2-targeted therapy. We studied the concordance of HER2 IHC and fluorescence in situ hybridization (FISH) as well as reproducibility of surgical pathologist (SP) and cytotechnologist (CT) interpretations using manual and image analysis methodologies on 154 IHC cases. Concordances with FISH were good for IHC negative (0, 1+) cases (range, 97%-100%) and positive (3+) cases (range, 87%-100%). Image analysis had fewer equivocal (2+) results (10.4%) than CT (14.9%) and SP (16.2%) manual methods, with higher concordances to FISH (31%, 26%, and 20% for image analysis, CT manual, and SP manual, respectively). CT manual (κ = 0.747) and image analysis (κ = 0.779) methods had better interobserver reproducibility than SP manual (κ = 0.697). CT image analysis had better intraobserver reproducibility (κ = 0.882) than CT (κ = 0.828) and SP (κ = 0.766) manual methods. HER2 IHC analysis performed by image analysis can produce accurate results with improved reproducibility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22261453     DOI: 10.1309/AJCP9MKNLHQNK2ZX

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma.

Authors:  Annette Feuchtinger; Tabitha Stiehler; Uta Jütting; Goran Marjanovic; Birgit Luber; Rupert Langer; Axel Walch
Journal:  Histochem Cell Biol       Date:  2014-08-26       Impact factor: 4.304

2.  Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET.

Authors:  Ganesan Vaidyanathan; Darryl McDougald; Jaeyeon Choi; Eftychia Koumarianou; Douglas Weitzel; Takuya Osada; H Kim Lyerly; Michael R Zalutsky
Journal:  J Nucl Med       Date:  2016-02-18       Impact factor: 10.057

3.  High in-vivo stability in preclinical and first-in-human experiments with [18F]AlF-RESCA-MIRC213: a 18F-labeled nanobody as PET radiotracer for diagnosis of HER2-positive cancers.

Authors:  Xue Qin; Xiaoyi Guo; Tianyu Liu; Liqiang Li; Nina Zhou; Xiaopan Ma; Xiangxi Meng; Jiayue Liu; Hua Zhu; Bing Jia; Zhi Yang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-21       Impact factor: 10.057

4.  Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists.

Authors:  Marilyn M Bui; Michael W Riben; Kimberly H Allison; Elizabeth Chlipala; Carol Colasacco; Andrea G Kahn; Christina Lacchetti; Anant Madabhushi; Liron Pantanowitz; Mohamed E Salama; Rachel L Stewart; Nicole E Thomas; John E Tomaszewski; M Elizabeth Hammond
Journal:  Arch Pathol Lab Med       Date:  2019-01-15       Impact factor: 5.534

5.  Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry.

Authors:  Henrik O Helin; Vilppu J Tuominen; Onni Ylinen; Heikki J Helin; Jorma Isola
Journal:  Virchows Arch       Date:  2015-10-22       Impact factor: 4.064

6.  HER2 mRNA status contributes to the discrepancy between gene amplification and protein overexpression in gastric cancer.

Authors:  Gui-Fen Ma; Yi-Mei Liu; Hong Gao; Qing Miao; Tian-Cheng Luo; Xiao-Qing Zeng; Shi-Yao Chen
Journal:  Dig Dis Sci       Date:  2013-11-02       Impact factor: 3.199

7.  Whole slide imaging for human epidermal growth factor receptor 2 immunohistochemistry interpretation: Accuracy, Precision, and reproducibility studies for digital manual and paired glass slide manual interpretation.

Authors:  David C Wilbur; Elena F Brachtel; John R Gilbertson; Nicholas C Jones; John G Vallone; Savitra Krishnamurthy
Journal:  J Pathol Inform       Date:  2015-05-28

8.  Comparative study between quantitative digital image analysis and fluorescence in situ hybridization of breast cancer equivocal human epidermal growth factor receptors 2 score 2(+) cases.

Authors:  Essam Ayad; Mina Mansy; Dalal Elwi; Mostafa Salem; Mohamed Salama; Klaus Kayser
Journal:  J Pathol Inform       Date:  2015-06-03

9.  Afatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivo.

Authors:  Siao-Syun Guan; Jungshan Chang; Chun-Chia Cheng; Tsai-Yueh Luo; Ai-Sheng Ho; Chia-Chi Wang; Cheng-Tien Wu; Shing-Hwa Liu
Journal:  Oncotarget       Date:  2014-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.